Pre-surgical Phase IIb Trial of Transdermal 4-Hydroxytamoxifen vs. Oral Tamoxifen in Women With Ductal Carcinoma in Situ of the Breast
Phase of Trial: Phase II
Latest Information Update: 23 Jul 2015
At a glance
- Drugs Afimoxifene (Primary) ; Tamoxifen
- Indications Breast cancer
- Focus Biomarker; Pharmacogenomic; Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 20 Jul 2015 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 02 May 2013 Status changed from suspended to active, no longer recruiting as reported by ClinicalTrials.gov.